Skip to main content

Using Decision Analysis to Support the Design of Clinical Trials Within a Program

  • Chapter
  • First Online:
Optimization of Pharmaceutical R&D Programs and Portfolios
  • 1718 Accesses

Abstract

Drug development involves complex, high-value decisions with lasting consequences. These decisions are made in the context of uncertainty, with information of many different types and from many different sources. A project team making a decision regarding the development of a drug needs to structure and synthesize this information in this context and come to a consensus on the best course of action.

Richard Nixon and Blair Ireland are employees of Novartis. The views expressed in this chapter are the views of the authors and do not necessarily reflect the views of Novartis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Burman CF, Wiklund SJ (2011) Modelling and simulation in the pharmaceutical industry-some reflections. Pharm Stat 10:508–516

    Article  Google Scholar 

  2. Matheson D, Matheson J (1998) The smart organization creating value through strategic R & D. Harvard Business School Press, Boston

    Google Scholar 

  3. O’Hagan A (2006) Uncertain judgements: eliciting experts’ probabilities. Wiley, Chichester

    Book  Google Scholar 

  4. PMDA (2007) Basic principles on global clinical trials. http://www.pmda.go.jp/english/service/pdf/notifications/PFSB-ELD-0928010.pdf

  5. R Core Team (2014) R: a language and environment for statistical computing. http://www.R-project.org

  6. Sheiner LB, Steimer JL (2000) Pharmacokinetic/pharmacodynamic modeling in drug development. Annu Rev Pharmacol Toxicol 40:67–95

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard Nixon .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Nixon, R., Ireland, B. (2015). Using Decision Analysis to Support the Design of Clinical Trials Within a Program. In: Antonijevic, Z. (eds) Optimization of Pharmaceutical R&D Programs and Portfolios. Springer, Cham. https://doi.org/10.1007/978-3-319-09075-7_7

Download citation

Publish with us

Policies and ethics